It’s been 17 years in the making, but Acumen Pharmaceuticals hasn’t given up hope for its approach to a disease-modifying drug for Alzheimer’s disease. After restructuring to become a virtual ...
Read more
May 23 (Reuters) - Johnson & Johnson said on Thursday that it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis ...
Read more
CHICAGO (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped ...
Read more
It’s time to do an update on the treatment of atrial fibrillation. It’s been a while, and there are worthy things to report from the real world. Stroke prevention in ...
Read more
NEW YORK (Reuters Health) - In a new study, people with high blood pressure who could communicate with their pharmacists online had better blood pressure control a year after that ...
Read more
NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of ...
Read more
It’s notoriously difficult to secure funding for the pre-clinical stage of drug development. Risk averse investors don’t want to take a chance on research where there’s a high risk of ...
Read more
A spinoff of Epitomics (now owned by Abcam) that’s using the biotech’s rabbit monoclonal antibody technology to discover and develop new cancer drugs has raised at least $15 million.According to ...
Read more
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making ...
Read more
(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a ...
Read more
As part of its efforts to give patients a stronger voice in clinical trial design, PatientsLikeMe has opened up a hub where researchers, clinicians, academics and patients can refine and ...
Read more
Biotechnology company Karyopharm Therapeutics has raised $48.2 million in a series B round for an innovative group of molecules to combat cancer, according to a company statement.Karyopharm’s approach, in phase ...
Read more
COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in ...
Read more
It was a big news for stem cells this week, particularly from a group of researchers who successfully transformed human skin cells into embryonic stem cells, showing that it’s possible ...
Read more
The “virtual” business models that have become common in many biotech startups may allow companies to operate with less capital, but they also present their own set of challenges.One of ...
Read more
